Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT

NCT07498517 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
90
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

OHSU Knight Cancer Institute

Collaborators